AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,904 | -18.7% | 11,433 | -72.8% | 0.00% | – |
| Q1 2023 | $58,896 | -29.2% | 41,979 | 0.0% | 0.00% | – |
| Q4 2022 | $83,129 | +1.4% | 41,979 | +6.4% | 0.00% | – |
| Q3 2022 | $82,000 | -61.7% | 39,443 | -40.1% | 0.00% | – |
| Q2 2022 | $214,000 | -9.3% | 65,903 | +17.3% | 0.00% | – |
| Q1 2022 | $236,000 | -13.2% | 56,168 | +0.1% | 0.00% | – |
| Q4 2021 | $272,000 | +205.6% | 56,107 | +199.2% | 0.00% | – |
| Q2 2020 | $89,000 | +29.0% | 18,751 | -8.7% | 0.00% | – |
| Q1 2020 | $69,000 | -80.3% | 20,549 | -71.8% | 0.00% | -100.0% |
| Q4 2019 | $351,000 | +0.3% | 72,980 | -39.6% | 0.00% | 0.0% |
| Q3 2019 | $350,000 | -21.3% | 120,774 | +285.2% | 0.00% | 0.0% |
| Q1 2019 | $445,000 | +27.1% | 31,356 | +20.9% | 0.00% | 0.0% |
| Q4 2018 | $350,000 | -44.9% | 25,937 | -9.4% | 0.00% | 0.0% |
| Q3 2018 | $635,000 | +55.3% | 28,613 | +14.9% | 0.00% | 0.0% |
| Q2 2018 | $409,000 | – | 24,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |